Inventor
TERENCE SEWARD BAKER
Inventor
GB
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides25%
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology6%
G06FElectric digital data processing3%
G16CComputational chemistry3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
12,545,720Anti-alpha-synuclein antibodies202612,410,244Anti-alpha-synuclein antibodies202512,327,613De novo antibody design202511,999,772Antibodies comprising a polypeptide inserted in framework 3 region202411,942,188Obtaining an improved therapeutic ligand202411,919,950Expression vector encoding antibody molecule which binds IL-17A and IL-17F202411,746,145Tau-binding antibodies202311,732,034Tau-binding antibodies202311,292,831Anti-alpha synuclein antibodies202211,261,242Anti-alpha-synuclein antibodies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to UCB Biopharma SRL (10)· patent assignee history
2022–2026Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UCB Biopharma SRL | 10 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 10 | 2022–2026 |